Congress trades

Sabra Health Care REIT, Inc. (SBRA)

NASDAQ · Real Estate · 8 congress trades · last filed 3 years ago

8
Congress disclosures shown
39d
Median delay on the congress disclosures
of the 45 day limit
5/3
Purchases and sales in the disclosures shown

About Sabra Health Care REIT, Inc.

from the company's filings and listing
Exchange
NASDAQ
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Chief executive
Richard K. Matros
Employees
58
Listed since
Apr 2, 2002
Market value
$5.2B
Price to earnings
78.7
Earnings per share
$0.26
Dividend yield
5.77%

www.sabrahealth.com

Earnings

6 reported quarters · next on Nov 4, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Aug 3, 2026-$0.10$0.17$235.9M$219.4MEPS missRevenue beat
Q1 FY2026reported Apr 29, 2026$0.16$0.17$221.8M$209.2MEPS missRevenue beat
Q4 FY2025reported Feb 12, 2026$0.11$0.17$211.9M$198.0MEPS missRevenue beat
Q3 FY2025reported Nov 5, 2025$0.09$0.18$190.0M$186.8MEPS missRevenue beat
Q2 FY2025reported Aug 4, 2025$0.28$0.18$189.2M$180.9MEPS beatRevenue beat
Q1 FY2025reported May 5, 2025$0.17$0.17$183.5M$179.0MEPS missRevenue beat

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for 2025 · proxy filed Apr 24, 2026
ExecutiveSalaryStock awardsOtherTotal
Richard K. MatrosChief Executive Officer, President & Chair of the Boar$1.0M$5.0M$2.5M$8.6M
Michael L. CostaChief Financial Officer, Executive Vice President & Tr$645K$2.0M$1.1M$3.8M

The summary compensation table from the 2025 proxy statement, current executives only. 1 executive who has since left the company is named in that filing and not shown here. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesChangeOf company
Blackrock, Inc.$811.9M41,614,351+6.4%16.50%
Principal Financial Group Inc$482.0M24,706,070-1.4%9.79%
Vanguard Portfolio Management LLC$455.6M23,352,373+0.9%9.26%
State Street Corp$240.1M12,305,655+1.7%4.88%
Vanguard Capital Management LLC$221.4M11,349,125+1.1%4.50%
Geode Capital Management, LLC$154.3M7,909,172+6.2%3.14%
Centersquare Investment Management LLC$113.4M5,814,427+49.9%2.30%
Bank Of America Corp$103.4M5,300,762-2.0%2.10%
Charles Schwab Investment Management Inc$94.4M4,840,401+1.4%1.92%
Sixth Street Partners Management Company, L.P.$94.4M4,840,401+100.0%1.92%
Nuveen, LLC$87.1M4,464,764-33.1%1.77%
Lasalle Investment Management Securities LLC$83.5M4,278,884+11.9%1.70%

A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.

Know the moment the next SBRA filing lands.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Congress trades in SBRA

8 disclosures of 8 on record · median 39d of the 45 allowed
MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Daniel S. GoldmanStockSale$1,001 - $15,000+80.0%S&P +86.2% · vs S&P 500 -6.2%Apr 10, 2023May 19, 202339d
Daniel S. GoldmanFiled lateStockPurchase$1,001 - $15,000+76.2%S&P +93.2% · vs S&P 500 -17.0%Mar 1, 2023Apr 17, 202347d
Lois FrankelStockSale$1,001 - $15,000+19.1%S&P +177.8% · vs S&P 500 -158.7%Mar 8, 2019Mar 27, 201919d
Lois FrankelStockSale$1,001 - $15,000+16.9%S&P +173.8% · vs S&P 500 -156.8%Mar 11, 2019Mar 27, 201916d
Gary J. PalmerJointFiled lateStockPurchase$1,001 - $15,000-8.7%S&P +173.6% · vs S&P 500 -182.3%Jul 12, 2018Sep 29, 201879d
Gary J. PalmerFiled lateStockPurchase$1,001 - $15,000-6.2%S&P +168.3% · vs S&P 500 -174.5%Aug 6, 2018Sep 29, 201854d
Lois FrankelStockPurchase$1,001 - $15,000-5.1%S&P +202.5% · vs S&P 500 -207.5%Oct 2, 2017Nov 3, 201732d
Lois FrankelStockPurchase$1,001 - $15,000-5.2%S&P +203.7% · vs S&P 500 -209.0%Sep 29, 2017Nov 3, 201735d

Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.

Questions

Which members of Congress have traded SBRA?

Daniel S. Goldman, Lois Frankel, Gary J. Palmer disclosed SBRA transactions in the filings shown here.

How quickly are SBRA trades disclosed?

Congressional disclosures took a median of 39 days, against the 45 the STOCK Act allows.

How to read a STOCK Act filing

WHAT THE FILING ACTUALLY SAYS

$A range, not an amount. Members disclose a band such as $1,001 to $15,000. The band is the filing, and we do not narrow it.
45Up to 45 days late, lawfully. The delay column counts calendar days from the transaction to its publication. Inside 45 days is within the law.
OPAn option names the underlying. A contract on a company is described using that company's name, so it can read like a share purchase. Those rows say otherwise.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Sep 10, 2026.

Related companies

traded by the same members

See every company we track